The DOI matches its Crossref record; 141 of the 141 references it cites were found in a registry or an index.
Insulin Degradation: Progress and Potential*
Open accessAbstract
Insulin degradation is a regulated process that plays a role in controlling insulin action by removing and inactivating the hormone. Abnormalities in insulin clearance and degradation are present in various pathological conditions including type 2 diabetes and obesity and may be important in producing clinical problems. The uptake, processing, and degradation of insulin by cells is a complex process with multiple intracellular pathways. Most evidence supports IDE as the primary degradative mechanism, but other systems (PDI, lysosomes, and other enzymes) undoubtedly contribute to insulin metabolism. Recent studies support a multifunctional role for IDE, as an intracellular binding, regulatory, and degradative protein. IDE increases proteasome and steroid hormone receptor activity, and this activation is reversed by insulin. This raises the possibility of a direct intracellular interaction of insulin with IDE that could modulate protein and fat metabolism. The recent findings would place intracellular insulin-IDE interaction into the insulin signal transduction pathway for mediating the intermediate effects of insulin on fat and protein turnover.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Role of Fatty Acids in the Pathogenesis of Insulin Resistance and NIDDM
Boden, G. (1997) · Diabetes · doi:10.2337/diab.46.1.3 · Cited by 1,728
Pathophysiology of insulin resistance in human disease
Reaven, G. M. (1995) · Physiological Reviews · doi:10.1152/physrev.1995.75.3.473 · Cited by 1,226
Evolutionary families of peptidases
Rawlings, N. D., & Barrett, A. J. (1993) · Biochemical Journal · doi:10.1042/bj2900205 · Cited by 923
A Phagosome-to-Cytosol Pathway for Exogenous Antigens Presented on MHC Class I Molecules
Kovacsovics-Bankowski, M., & Rock, K. L. (1995) · Science · doi:10.1126/science.7809629 · Cited by 884 · cited 1×
“Roth’s laboratory (98) showed that insulin added to intact cells could be cross-linked to cytosolic IDE similar to the phagosome-to-cytosol pathway for antigens (224).”
BackgroundInsulin Action and the Insulin Signaling Network*
CHEATHAM, B., & KAHN, C. R. (1995) · Endocrine Reviews · doi:10.1210/edrv-16-2-117 · Cited by 881
Protein disulfide isomerase: Multiple roles in the modification of nascent secretory proteins
Freedman, R. B. (1989) · Cell · doi:10.1016/0092-8674(89)90043-3 · Cited by 457
Daniel, D., & Wegmann, D. R. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.2.956 · Cited by 406
Evans, D. J., Hoffman, R. G., Kalkhoff, R. K., & Kissebah, A. H. (1984) · Metabolism · doi:10.1016/0026-0495(84)90164-1 · Cited by 390
Daniel, D., Gill, R. G., Schloot, N., & Wegmann, D. (1995) · European Journal of Immunology · doi:10.1002/eji.1830250430 · Cited by 358
Splanchnic insulin metabolism in obesity. Influence of body fat distribution.
Peiris, A. N., Mueller, R. A., Smith, G. A., Struve, M. F., & Kissebah, A. H. (1986) · Journal of Clinical Investigation · doi:10.1172/jci112758 · Cited by 346 · cited 1×
“function may be an integral part of this syndrome (29).”
Background
Research works printed but not linked: 97
- Duckworth, 1997, The significance of intracellular insulin to insulin action., J Invest Med, 45, 20
- Sonne, 1986, The reversible receptor binding of insulin in isolated rat adipocytes measured at 37 degrees: the binding is not rate limiting for cellular uptake., Biochim Biophys Acta, 886, 302, 10.1016/0167-4889(86)90149-7 · doi:10.1016/0167-4889(86)90149-7
- Sato, 1991, Receptor-recycling model of clearance and distribution of insulin in the perfused mouse liver., Diabetologia, 34, 613, 10.1007/BF00400989 · doi:10.1007/bf00400989
- Jochen, 1989, Kinetics of insulin internalization and processing in adipocytes: effects of insulin concentration., J Cell Physiol, 141, 527, 10.1002/jcp.1041410311 · doi:10.1002/jcp.1041410311
- Benzi, 1994, Insulin degradation in vitro and in vivo: a comparative study in men. Evidence that immunoprecipitable, partially rebindable degradation products are released from cells and circulate in blood., Diabetes, 43, 297, 10.2337/diab.43.2.297 · doi:10.2337/diab.43.2.297
- Caro, 1981, Evidence for modulation of insulin action and degradation independently of insulin binding, Am J Physiol, 240, E325
- Adrogue, 1996, Glyburide increases the secretion, tissue uptake, and action of insulin in conscious normal dogs., Metabolism, 45, 579, 10.1016/S0026-0495(96)90027-X · doi:10.1016/s0026-0495(96)90027-x
- Auletta, 1994, Insulin-degrading activity in experimental liver cirrhosis of the rat., Enzyme Protein, 95, 197, 10.1159/000474989 · doi:10.1159/000474989
- Antoniello, 1989, Insulin and glucagon degradation in liver are not affected by hepatic cirrhosis., Clin Chim Acta, 183, 343, 10.1016/0009-8981(89)90369-0 · doi:10.1016/0009-8981(89)90369-0
- Hysing, 1989, Renal Uptake and degradation of trapped-label insulin., Renal Physiol Biochem, 12, 228
- Nielsen, 1992, Time course and kinetics of proximal tubular processing of insulin, Am J Physiol, 262, F813
- Fawcett, 1995, Sequential processing of insulin by cultured kidney cells., Endocrinology, 136, 39, 10.1210/endo.136.1.7828556 · doi:10.1210/endo.136.1.7828556
- Surmacz, 1988, Uptake and intracellular fate of [14C] sucrose-insulin in perfused rat livers, Am J Physiol, 255, C70, 10.1152/ajpcell.1988.255.1.C70 · doi:10.1152/ajpcell.1988.255.1.c70
- Dahl, 1990, Effect of bacitracin on the retroendocytosis and degradation of insulin in cultured kidney epithelial cell line., Diabetes, 39, 1339, 10.2337/diab.39.11.1339 · doi:10.2337/diab.39.11.1339
- Vries, 1990, Effect of the insulin degradation inhibitors bacitracin and chloroquine on insulin binding data to H35 rat hepatoma cells., Diabete Metab, 16, 70
- Medina, 1993, Purification of nonantibiotic insulinase inhibitors from bacitracin., Biochem Med Metab Biol, 49, 255, 10.1006/bmmb.1993.1027 · doi:10.1006/bmmb.1993.1027
- Heckmeyer, 1982, Selective antilipolytic effect of bacitracin in the isolated fat cell., Biochem Biophys Res Commun, 108, 336, 10.1016/0006-291X(82)91871-X · doi:10.1016/0006-291x(82)91871-x
- Rabkin, 1979, Effect of prolonged uremia on insulin metabolism by isolated liver and muscle., Kidney Int, 16, 433, 10.1038/ki.1979.148 · doi:10.1038/ki.1979.148
- Jochen, 1987, Effects of metalloendoprotease inhibitors on insulin binding, internalization and processing in adipocytes., Biochem Biophys Res Commun, 142, 205, 10.1016/0006-291X(87)90472-4 · doi:10.1016/0006-291x(87)90472-4
- Ardevol, 1996, Adipose tissue extraction of circulating insulin in anaesthetized Zucker obese rats., Int J Obes, 20, 837
- Baldwin Jr, 1981, Insulin binding, internalization, and receptor regulation in cultured human fibroblasts, Am J Physiol, 241, E251
- Powers, 1980, Insulin degradation by mononuclear cells., Diabetes, 29, 27, 10.2337/diab.29.1.27 · doi:10.2337/diab.29.1.27
- Bai, 1995, Insulin-degrading enzyme in a human colon adenocarcinoma cell line (Caco-2)., Pharm Res, 12, 513, 10.1023/A:1016241610649 · doi:10.1023/a:1016241610649
- Huber, 1980, The time course of insulin degradation in the perifused isolated fat cell., J Clin Invest, 65, 461, 10.1172/JCI109689 · doi:10.1172/jci109689
- Hamel, 1987, High performance liquid chromatographic analysis of insulin degradation products from isolated hepatocytes: effects of inhibitors suggest intracellular and extracellular pathways., Diabetes, 36, 702, 10.2337/diab.36.6.702 · doi:10.2337/diab.36.6.702
- Smith, 1990, Differences in adenosine triphosphate dependency of receptor-mediated endocytosis ofα 2-macroglobulin and insulin correlate with separate routes of ligand-receptor complex internalization., Endocrinology, 126, 1551, 10.1210/endo-126-3-1551 · doi:10.1210/endo-126-3-1551
- Thompson, 1989, Intranuclear localization of insulin in rat hepatoma cells: insulin/matrix association., Eur J Cell Biol, 50, 442
- Smith, 1990, Partial characterization of mechanism of insulin accumulation in H35 hepatoma cell nuclei., Diabetes, 39, 683, 10.2337/diab.39.6.683 · doi:10.2337/diab.39.6.683
- Goldfine, 1981, Electron microscope autoradiographic analysis of 125I iodoinsulin entry into adult rat hepatocytes in vivo: evidence for multiple sites of hormone localization., Endocrinology, 108, 1821, 10.1210/endo-108-5-1821 · doi:10.1210/endo-108-5-1821
- Smith, 1989, Biology of disease, Receptor-mediated endocytosis and intracellular processing of insulin: ultrastructural and biochemical evidence for cell-specific heterogeneity and distinction from nonhormonal ligands. In: Rubin E, Damjanov I (eds) Pathology Reviews. Humana Press Inc., Clifton, NJ, pp, 37
- Levy, 1987, The effect of insulin concentration on retroendocytosis in isolated rat adipocytes., Endocrinology, 120, 450, 10.1210/endo-120-2-450 · doi:10.1210/endo-120-2-450
- Pell, 1986, Localization of insulin degradation products to an intracellular site in isolated rat hepatocytes., Biochem Biophys Res Commun, 137, 1034, 10.1016/0006-291X(86)90329-3 · doi:10.1016/0006-291x(86)90329-3
- Clot, 1990, Characterization of insulin degradation products generated in liver endosomes: in vivo and in vitro studies., Mol Cell Endocrinol, 72, 175, 10.1016/0303-7207(90)90142-U · doi:10.1016/0303-7207(90)90142-u
- Berhanu, 1988, Internalized insulin-receptor complexes are unidirectionally translocated to chloroquine-sensitive degradative sites., J Biol Chem, 263, 5961, 10.1016/S0021-9258(18)60660-X · doi:10.1016/s0021-9258(18)60660-x
- Calzi, 1997, Differential effect of pp120 on insulin endocytosis by two variant insulin receptor isoforms, Am J Physiol, 273, E801
- Hamel, 1988, Isolation of insulin degradation products from endosomes derived from intact rat liver., J Biol Chem, 263, 6703, 10.1016/S0021-9258(18)68699-5 · doi:10.1016/s0021-9258(18)68699-5
- Duckworth, 1990, Cellular and endosomal degradation, In: Nishizuka Y, Endok M, Tanaka C (eds) The Biology and Medicine of Signal Transduction. Raven Press, New York, pp, 521
- Williams, 1990, [125I]-insulin metabolism by the rat liver in vivo: evidence that a neutral thiol-protease mediates rapid intracellular insulin degradation., Metabolism, 39, 231, 10.1016/0026-0495(90)90041-A · doi:10.1016/0026-0495(90)90041-a
- Seabright, 1996, The characterization of endosomal insulin degradation intermediates and their sequence of production., Biochem J, 320, 947, 10.1042/bj3200947 · doi:10.1042/bj3200947
- Akiyama, 1990, Natural regulatory mechanisms of insulin degradation by insulin degrading enzyme., Biochem Biophys Res Commun, 170, 1325, 10.1016/0006-291X(90)90539-Y · DOI
- Davies, 1986, Identification of some cleavage sites of insulin by insulin proteinase., Biochem J, 240, 609, 10.1042/bj2400609 · doi:10.1042/bj2400609
- Davies, 1988, Identification of radioactive insulin fragments liberated during the degradation of semisynthetic [3H]GlyA1 insulin and [3H]PheB1 insulin., Biochem J, 249, 209, 10.1042/bj2490209 · doi:10.1042/bj2490209
- Duckworth, 1988, High performance liquid chromatographic analysis of insulin degradation products from a cultured kidney cell line., Endocrinology, 123, 2701, 10.1210/endo-123-6-2701 · doi:10.1210/endo-123-6-2701
- Duckworth, 1987, Identification of A chain cleavage sites in intact insulin produced by insulin protease and isolated hepatocytes., Biochem Biophys Res Commun, 147, 615, 10.1016/0006-291X(87)90975-2 · doi:10.1016/0006-291x(87)90975-2
- Duckworth, 1989, High performance liquid chromatographic analysis of insulin degradation products from perfused rat kidney, Am J Physiol, 256, E208
- Hamel, 1986, High performance liquid chromatographic analysis of insulin degradation by rat skeletal muscle insulin protease., Endocrinology, 118, 328, 10.1210/endo-118-1-328 · doi:10.1210/endo-118-1-328
- Savoy, 1988, Identification by fast atom bombardment mass spectrometry of insulin fragments produced by insulin proteinase., Biochem J, 249, 215, 10.1042/bj2490215 · doi:10.1042/bj2490215
- Ryan, 1988, Insulin degradation: assays and enzymes. In: Kahn C, Harrison L (eds) The Insulin Receptor. Alan R. Liss, Inc.,, New York, vol, 1, 29
- Frank, 1983, Receptor binding properties of monoiodotyrosyl insulin isomers purified by high performance liquid chromatography., Diabetes, 32, 705, 10.2337/diab.32.8.705 · doi:10.2337/diab.32.8.705
- Ryan, 1984, The degradation of monoiodotyrosyl insulin isomers by insulin protease., Endocrinology, 115, 591, 10.1210/endo-115-2-591 · doi:10.1210/endo-115-2-591
- Mirsky, 1949, The inactivation of insulin by tissue extracts. I. The distribution and properties of insulin inactivating extracts (insulinase)., Arch Biochem, 20, 1
- Ryan, 1985, The calcium dependence of insulin degradation by rat skeletal muscle., Endocrinology, 117, 1693, 10.1210/endo-117-4-1693 · doi:10.1210/endo-117-4-1693
- Duckworth, 1994, Editorial: Increasing understanding of calmodulin-insulin interactions., J Lab Clin Med, 124, 311
- Duckworth, 1990, Human red blood cell insulin-degrading enzyme and rat skeletal muscle insulin protease share antigenic sites and generate identical products from insulin., J Biol Chem, 265, 2984, 10.1016/S0021-9258(19)39898-9 · doi:10.1016/s0021-9258(19)39898-9
- Gehm, 1993, Mutations in a zinc-binding domain of human insulin-degrading enzyme eliminate catalytic activity but not insulin binding., J Biol Chem, 268, 7943, 10.1016/S0021-9258(18)53049-0 · doi:10.1016/s0021-9258(18)53049-0
- Ryan, 1983, Partial characterization of an endogenous inhibitor of a calcium-dependent form of insulin protease., Biochem Biophys Res Commun, 116, 195, 10.1016/0006-291X(83)90400-X · doi:10.1016/0006-291x(83)90400-x
- Dykstra, 1985, Physical characterization of the cloned protease III gene from Escherichia coli K-12., J Bacteriol, 163, 1055, 10.1128/JB.163.3.1055-1059.1985 · doi:10.1128/jb.163.3.1055-1059.1985
- Cheng, 1979, Purification and characterization of protease III from Escherichia coli., J Biol Chem, 254, 4698, 10.1016/S0021-9258(17)30068-6 · doi:10.1016/s0021-9258(17)30068-6
- Ding, 1992, Comparison of the enzymatic and biochemical properties of human insulin-degrading enzyme and Escherichia coli protease III., J Biol Chem, 267, 2414, 10.1016/S0021-9258(18)45895-4 · doi:10.1016/s0021-9258(18)45895-4
- Kole, 1991, Purification and properties of a membrane-bound insulin binding protein, a putative receptor, from Neurospora crassa., Biochemistry, 30, 682, 10.1021/bi00217a014 · doi:10.1021/bi00217a014
- Kole, 1992, Characterization and partial purification of an insulinase from Neurospora crassa., Arch Biochem Biophys, 297, 199, 10.1016/0003-9861(92)90662-G · doi:10.1016/0003-9861(92)90662-g
- Fricke, 1995, A periplasmic insulin-cleaving proteinase (ICP) from Acinetobacter calcoaceticus sharing properties with protease III from Escherichia coli and IDE from eucaryotes., J Basic Microbiol, 35, 21, 10.1002/jobm.3620350107 · doi:10.1002/jobm.3620350107
- McKenzie, 1984, Partial purification and characterization of insulin protease and its intracellular inhibitor from rat liver., Arch Biochem Biophys, 229, 604, 10.1016/0003-9861(84)90193-0 · doi:10.1016/0003-9861(84)90193-0
- Duckworth, 1978, Insulin and glucagon binding and degradation by the kidney cell membrane., Endocrinology, 102, 1766, 10.1210/endo-102-6-1766 · doi:10.1210/endo-102-6-1766
- Duckworth, 1979, Insulin degradation by liver cell membranes., Endocrinology, 104, 1758, 10.1210/endo-104-6-1758 · doi:10.1210/endo-104-6-1758
- Yokono, 1979, Insulin-degrading activity of plasma membranes from rat skeletal muscle: its isolation, characterization, and biologic significance., Diabetes, 28, 810, 10.2337/diab.28.9.810 · doi:10.2337/diab.28.9.810
- Rabkin, 1992, Insulin degrading enzyme (IDE) in renal proximal tubules., Diabetes, 41, 15
- Hamel, 1997, Identification of the cleavage sites of transforming growth factor-alpha by insulin degrading enzymes., Biochim Biophys Acta, 1338, 207, 10.1016/S0167-4838(96)00202-6 · doi:10.1016/s0167-4838(96)00202-6
- Thompson, 1985, Identification of a novel receptor in Drosophila for both epidermal growth factor and insulin., Proc Natl Acad Sci USA, 82, 8443, 10.1073/pnas.82.24.8443 · doi:10.1073/pnas.82.24.8443
- Hamel, 1997, Intraendosomal degradation of transforming growth factor alpha., Mol Cell Endocrinol, 126, 185, 10.1016/S0303-7207(96)03981-0 · doi:10.1016/s0303-7207(96)03981-0
- Schade, 1985, The etiology of incapacitating brittle diabetes., Diabetes Care, 8, 18, 10.2337/diacare.8.1.12 · DOI
- Schade, 1985, A clinical algorithm to determine the etiology of brittle diabetes., Diabetes Care, 8, 5, 10.2337/diacare.8.1.5 · doi:10.2337/diacare.8.1.5
- Lau, 1990, Proteolytic degradation of human recombinant proinsulin/insulin by sera from acute pancreatitis patients and complete inhibition by Eglin-C., Pancreas, 5, 17, 10.1097/00006676-199001000-00003 · doi:10.1097/00006676-199001000-00003
- Stoppelli, 1988, Developmental regulation of an insulin degrading enzyme from Drosophila melanogaster., Proc Natl Acad Sci USA, 85, 3469, 10.1073/pnas.85.10.3469 · doi:10.1073/pnas.85.10.3469
- Kayalar, 1990, Differentiation of BC3H1 and primary skeletal muscle cells and the activity of their endogenous insulin-degrading enzyme are inhibited by the same metalloendoprotease inhibitors., J Cell Biochem, 44, 137, 10.1002/jcb.240440303 · doi:10.1002/jcb.240440303
- Naquet, 1987, Processing and presentation of insulin. I. Analysis of immunogenic peptides and processing requirements for insulin. A loop-specific T cells., J Immunol, 139, 3955, 10.4049/jimmunol.139.12.3955 · doi:10.4049/jimmunol.139.12.3955
- Semple, 1989, Processing and presentation of insulin. II. Evidence for intracellular, plasma membrane-associated and extracellular degradation of human insulin by antigen presenting B cells., J Immunol, 142, 4184, 10.4049/jimmunol.142.12.4184 · doi:10.4049/jimmunol.142.12.4184
- Delovitch, 1988, Pathways of processing of insulin by antigen-presenting cells., Immunol Rev, 106, 195, 10.1111/j.1600-065X.1988.tb00780.x · doi:10.1111/j.1600-065x.1988.tb00780.x
- Pierotti, 1994, N-Arginine dibasic convertase, a metalloendopeptidase as a prototype of a class of processing enzymes., Proc Natl Acad Sci USA, 91, 6078, 10.1073/pnas.91.13.6078 · doi:10.1073/pnas.91.13.6078
- Blache, 1992, Purification and partial characterization of the liver membrane endopeptidase which transforms glucagon into glucagon (19–29)., Biomed Res, 13, 51
- Varandani, 1972, Sequential degradation of insulin by rat liver homogenates., Proc Natl Acad Sci USA, 69, 1681, 10.1073/pnas.69.7.1681 · doi:10.1073/pnas.69.7.1681
- Varandani, 1980, Role of the biodegradation process in the action of insulin, A proposal for a model consisting of sulfhydryl-disulfide interchange reacter and proteolysis. In: Brandenburg D, Wollmer A (eds) Insulin, Chemistry, Structure and Function of Insulin and Related Hormones. Walter de Grayter, Berlin, pp, 475
- Roth, 1981, Role of disulfide interchange enzyme in immunoglobulin synthesis., Biochemistry, 20, 6594, 10.1021/bi00526a012 · doi:10.1021/bi00526a012
- Duckworth, 1990, Insulin degrading enzyme. In: Cuatrecasas P, Jacobs S (eds) The Handbook of Experimental Pharmacology., Springer-Verlag Press, Berlin, vol, 92, 143
- Pease, 1985, Degradation of endocytosed insulin in rat liver is mediated by low density vesicles., Biochem J, 228, 137, 10.1042/bj2280137 · doi:10.1042/bj2280137
- Bergeron, 1986, Differential and analytical subfractionation of rat liver components internalizing insulin and prolactin., Biochemistry, 25, 1756, 10.1021/bi00355a046 · doi:10.1021/bi00355a046
- Ward, 1985, Effects of lysosomal inhibitors on 125I insulin and 125I asioalofetuin degradation by the isolated, perfused rat liver and isolated rat hepatocytes., Diabetes, 34, 446, 10.2337/diab.34.5.446 · doi:10.2337/diab.34.5.446
- Ali, 1989, Glucocorticoid regulation of chloroquine nonsensitive insulin degradation in cultured fetal rat heaptocytes., J Biol Chem, 264, 20992, 10.1016/S0021-9258(19)30034-1 · doi:10.1016/s0021-9258(19)30034-1
- Bennett, 1996, Insulin inhibition of fatty acid β-oxidation in isolated peroxisomes., Diabetes, 45, 310
- Tsao, 1990, Modulation of kidney cell protein degradation by insulin., J Lab Clin Med, 116, 369
- Hofmann, 1983, Insulin-ricin B hybrid molecules mediate an insulin-associated effect on cells which do not bind insulin., J Biol Chem, 258, 11774, 10.1016/S0021-9258(17)44297-9 · doi:10.1016/s0021-9258(17)44297-9
- Miller, 1989, Stimulation of protein synthesis in stage IV Xenopus oocytes by microinjected insulin., J Biol Chem, 264, 10438, 10.1016/S0021-9258(18)81640-4 · doi:10.1016/s0021-9258(18)81640-4
- Miller, 1988, Stimulation of RNA and protein synthesis by intracellular insulin., Science, 240, 506, 10.1126/science.2451860 · doi:10.1126/science.2451860
- Miller, 1991, Stimulation of protein synthesis by internalized insulin., J Cell Physiol, 147, 487, 10.1002/jcp.1041470315 · doi:10.1002/jcp.1041470315
- Draznin, 1982, Inhibition of intracellular proteolysis by insulin in isolated rat hepatocytes: possible role of internalized hormone., J Biol Chem, 257, 11988, 10.1016/S0021-9258(18)33665-2 · doi:10.1016/s0021-9258(18)33665-2
- Peavy, 1984, Selective effects of inhibitors of hormone processing on insulin action in isolated hepatocytes., Endocrinology, 114, 753, 10.1210/endo-114-3-753 · doi:10.1210/endo-114-3-753
- Bennett, 1997, Characterization of the insulin inhibition of the peptidolytic activities of the insulin-degrading enzyme-proteasome complex., Diabetes, 46, 197, 10.2337/diab.46.2.197 · doi:10.2337/diab.46.2.197
Cited by
Energy Metabolism in the Liver
Rui, L. (2014) · Comprehensive Physiology · doi:10.1002/cphy.c130024 · Cited by 1,953
Michael, M. D., Kulkarni, R. N., Postic, C., Previs, S. F., Shulman, G. I., Magnuson, M. A., & Kahn, C. R. (2000) · Molecular Cell · doi:10.1016/s1097-2765(05)00015-8 · Cited by 1,296
Why does obesity cause diabetes?
Klein, S., Gastaldelli, A., Yki-Järvinen, H., & Scherer, P. E. (2022) · Cell Metabolism · doi:10.1016/j.cmet.2021.12.012 · Cited by 939
Leissring, M. A., Farris, W., Chang, A. Y., Walsh, D. M., Wu, X., Sun, X., Frosch, M. P., & Selkoe, D. J. (2003) · Neuron · doi:10.1016/s0896-6273(03)00787-6 · Cited by 719
New Perspectives into the Molecular Pathogenesis and Treatment of Type 2 Diabetes
Saltiel, A. R. (2001) · Cell · doi:10.1016/s0092-8674(01)00239-2 · Cited by 692
Schalkwijk, C. G., & Stehouwer, C. D. A. (2020) · Physiological Reviews · doi:10.1152/physrev.00001.2019 · Cited by 622
Development and Challenges of Antimicrobial Peptides for Therapeutic Applications
Chen, C. H., & Lu, T. K. (2020) · Antibiotics · doi:10.3390/antibiotics9010024 · Cited by 598
Islet Amyloid: A Critical Entity in the Pathogenesis of Type 2 Diabetes
Hull, R. L., Westermark, G. T., Westermark, P., & Kahn, S. E. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0405 · Cited by 583
Liu, C., Wu, H., Hsiao, Y., Lai, C., Shih, C., Peng, Y., Tang, K., Chang, H., Chien, Y., Hsiao, J., et al. (2011) · Angewandte Chemie International Edition · doi:10.1002/anie.201100299 · Cited by 421
Clearance of Alzheimer's Aβ Peptide
Tanzi, R. E., Moir, R. D., & Wagner, S. L. (2004) · Neuron · doi:10.1016/j.neuron.2004.08.024 · Cited by 411
Zhou, X. J., Rakheja, D., Yu, X., Saxena, R., Vaziri, N. D., & Silva, F. G. (2008) · Kidney International · doi:10.1038/ki.2008.319 · Cited by 396
Matrix Metalloproteinases Expressed by Astrocytes Mediate Extracellular Amyloid-β Peptide Catabolism
Yin, K.-J., Cirrito, J. R., Yan, P., Hu, X., Xiao, Q., Pan, X., Bateman, R., Song, H., Hsu, F.-F., Turk, J., et al. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.2085-06.2006 · Cited by 381
Miners, J. S., Baig, S., Palmer, J., Palmer, L. E., Kehoe, P. G., & Love, S. (2008) · Brain Pathology · doi:10.1111/j.1750-3639.2008.00132.x · Cited by 381
Structures of human insulin-degrading enzyme reveal a new substrate recognition mechanism
Shen, Y., Joachimiak, A., Rich Rosner, M., & Tang, W.-J. (2006) · Nature · doi:10.1038/nature05143 · Cited by 375
Natriuretic peptide metabolism, clearance and degradation
Potter, L. R. (2011) · The FEBS Journal · doi:10.1111/j.1742-4658.2011.08082.x · Cited by 357
Cook, D. G., Leverenz, J. B., McMillan, P. J., Kulstad, J. J., Ericksen, S., Roth, R. A., Schellenberg, G. D., Jin, L.-W., Kovacina, K. S., & Craft, S. (2003) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63822-9 · Cited by 331
Kabir, M., Catalano, K. J., Ananthnarayan, S., Kim, S. P., Van Citters, G. W., Dea, M. K., & Bergman, R. N. (2005) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00203.2004 · Cited by 327
Volpe, M., Carnovali, M., & Mastromarino, V. (2015) · Clinical Science · doi:10.1042/cs20150469 · Cited by 305
CEACAM1 regulates insulin clearance in liver
Poy, M. N., Yang, Y., Rezaei, K., Fernström, M. A., Lee, A. D., Kido, Y., Erickson, S. K., & Najjar, S. M. (2002) · Nature Genetics · doi:10.1038/ng840 · Cited by 271
Farris, W., Mansourian, S., Leissring, M. A., Eckman, E. A., Bertram, L., Eckman, C. B., Tanzi, R. E., & Selkoe, D. J. (2004) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63229-4 · Cited by 269
Aβ-degrading enzymes: potential for treatment of Alzheimer disease
Miners, J. S., Barua, N., Kehoe, P. G., Gill, S., & Love, S. (2011) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3182345e46 · Cited by 265
Meier, J. J., Veldhuis, J. D., & Butler, P. C. (2005) · Diabetes · doi:10.2337/diabetes.54.6.1649 · Cited by 261
Anti-diabetic activity of insulin-degrading enzyme inhibitors mediated by multiple hormones
Maianti, J. P., McFedries, A., Foda, Z. H., Kleiner, R. E., Du, X. Q., Leissring, M. A., Tang, W.-J., Charron, M. J., Seeliger, M. A., Saghatelian, A., et al. (2014) · Nature · doi:10.1038/nature13297 · Cited by 254
Li, J., Kuang, Y., & Mason, C. C. (2006) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2006.04.002 · Cited by 241
The extracellular matrix and insulin resistance
Williams, A. S., Kang, L., & Wasserman, D. H. (2015) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2015.05.006 · Cited by 228
Insulin Secretion during and after Pregnancy in Patients with Gestational Diabetes Mellitus1
Homko, C., Sivan, E., Chen, X., Reece, E. A., & Boden, G. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.2.7137 · Cited by 217
Insulin resistance and PCOS: chicken or egg?
Moghetti, P., & Tosi, F. (2021) · Journal of Endocrinological Investigation · doi:10.1007/s40618-020-01351-0 · Cited by 209
Shao, N., Kuang, H. Y., Hao, M., Gao, X. Y., Lin, W. J., & Zou, W. (2014) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2561 · Cited by 185
Amyloid β-degrading cryptidases: insulin degrading enzyme, presequence peptidase, and neprilysin
Malito, E., Hulse, R. E., & Tang, W.-J. (2008) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-008-8112-4 · Cited by 176
Pulsatile Portal Vein Insulin Delivery Enhances Hepatic Insulin Action and Signaling
Matveyenko, A. V., Liuwantara, D., Gurlo, T., Kirakossian, D., Dalla Man, C., Cobelli, C., White, M. F., Copps, K. D., Volpi, E., Fujita, S., et al. (2012) · Diabetes · doi:10.2337/db11-1462 · Cited by 163
Pugliese, G., Penno, G., Natali, A., Barutta, F., Di Paolo, S., Reboldi, G., Gesualdo, L., & De Nicola, L. (2019) · Nutrition, Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2019.07.017 · Cited by 156
Insulin-degrading enzyme identified as a candidate diabetes susceptibility gene in GK rats
Fakhrai-Rad, H. (2000) · Human Molecular Genetics · doi:10.1093/hmg/9.14.2149 · Cited by 155
“In addition, proinsulin, IGF-I and epidermal growth factor bind, but are poorly degraded by IDE (27).”
BackgroundZorzi, A., Middendorp, S. J., Wilbs, J., Deyle, K., & Heinis, C. (2017) · Nature Communications · doi:10.1038/ncomms16092 · Cited by 141
“To give some indication of the fast renal clearance of proteolytically stable peptide drugs, insulin, once in the blood stream has a half-life of 4–6 min 4 .”
Insulin Glargine Safety in Pregnancy
Pollex, E. K., Feig, D. S., Lubetsky, A., Yip, P. M., & Koren, G. (2010) · Diabetes Care · doi:10.2337/dc09-1045 · Cited by 104
“However, at very high concentrations, it has been suggested that non– receptor-mediated processes, such as pinocytosis, may also be involved in insulin transport across cell membranes in other tissues (14).”
BackgroundAnalysis of a model of the glucose-insulin regulatory system with two delays
Li, J., & Kuang, Y. (2007) · SIAM Journal on Applied Mathematics · doi:10.1137/050634001 · Cited by 96
Smith, G. I., Polidori, D. C., Yoshino, M., Kearney, M. L., Patterson, B. W., Mittendorfer, B., & Klein, S. (2020) · Journal of Clinical Investigation · doi:10.1172/jci136756 · Cited by 78
Piccinini, F., Polidori, D. C., Gower, B. A., & Bergman, R. N. (2017) · Diabetes · doi:10.2337/db17-0413 · Cited by 73
“The receptor is finally recycled in a vesicle back to the plasma membrane (28).”
BackgroundInfluentialInsulin Metabolism in Polycystic Ovary Syndrome: Secretion, Signaling, and Clearance
Herman, R., Sikonja, J., Jensterle, M., Janez, A., & Dolzan, V. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24043140 · Cited by 69
“MCRI is determined by the efficiency of the insulin degradation process, which involves the internalization of the insulin-receptor complex and is followed by insulin degradation in the cytoplasm, carried out by insulin-degrading enzyme and other lysosomal enzymes [84,85].”
BackgroundMatveyenko, A. V., Veldhuis, J. D., & Butler, P. C. (2008) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.90451.2008 · Cited by 54
Loss of transcriptional repression by BCL6 confers insulin sensitivity in the setting of obesity
Senagolage, M. D., Sommars, M. A., Ramachandran, K., Futtner, C. R., Omura, Y., Allred, A. L., Wang, J., Yang, C., Procissi, D., Evans, R. M., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.11.074 · Cited by 44
Muscle adaptation to short-term fasting in healthy lean humans
Soeters, M. R., Sauerwein, H. P., Dubbelhuis, P. F., Groener, J. E., Ackermans, M. T., Fliers, E., Aerts, J. M., & Serlie, M. J. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0250 · Cited by 40
Mull, R. W., Harrington, A., Sanchez, L. A., & Tal-Gan, Y. (2018) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026618666180518090705 · Cited by 41
Mathematical modeling and analysis of insulin clearance in vivo
Koschorreck, M., & Gilles, E. D. (2008) · BMC Systems Biology · doi:10.1186/1752-0509-2-43 · Cited by 35
MODELING EXERCISE EFFECTS IN TYPE I DIABETIC PATIENTS
Lenart, P. J., & Parker, R. S. (2002) · IFAC Proceedings Volumes · doi:10.3182/20020721-6-es-1901.01350 · Cited by 34
Leptin Deficiency Per Se Dictates Body Composition and Insulin Action in ob/ob Mice
Van Den Hoek, A. M., Teusink, B., Voshol, P. J., Havekes, L. M., Romijn, J. A., & Pijl, H. (2008) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2007.01626.x · Cited by 34
Incretin and Islet Hormone Responses to Meals of Increasing Size in Healthy Subjects
Alsalim, W., Omar, B., Pacini, G., Bizzotto, R., Mari, A., & Ahrén, B. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-2865 · Cited by 33
“Stimulated insulin secretion with hyperinsulinemia has been shown to reduce hepatic insulin extraction (28– 30) and thus insulin clearance (31).”
BackgroundSantiago, J. C. P., & Hallschmid, M. (2017) · Frontiers in Neuroscience · doi:10.3389/fnins.2017.00054 · Cited by 18
“…of the insulin molecule in the central nervous compartment can be assumed to be relatively delayed in comparison to its halflife in the circulation of 4–6 min (Duckworth et al., 1998), the enhanced brain insulin signal may in principle be still functionally active after a prolonged period of time.”
BackgroundThe Early Effect of Sunitinib on Insulin Clearance in Patients with Metastatic Renal Cell Carcinoma
Thijs, A. M. J., Tack, C. J., van der Graaf, W. T. A., Rongen, G. A., & van Herpen, C. M. L. (2016) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12797 · Cited by 5
Metadata
- Authors
- Duckworth, W. C., Bennett, R. G., & Hamel, F. G.
- Venue
- Endocrine Reviews
- Publisher
- The Endocrine Society
- Published
- 1998-10-01
- Volume
- 19
- Issue
- 5
- Pages
- 608-624
- ISSN
- 0163-769X (ISSN-L)
- 1945-7189
- OpenAlex
- W2138041386
- Cited by
- 871
- References
- 141
- FWCI
- 1.91
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.